AliveCor (San Francisco) reported that the FDA has granted clearance for two new algorithms giving users instant feedback on their electrocardiogram (ECG) recordings and expanding its automated interpretation service offerings. AliveCor's new analysis processes, or algorithms, include a Normal Detector designed to identify when no abnormalities are detected in an ECG recording, and an Interference Detector that identifies if factors have affected the recording making the ECG unreadable.